Abstract: The invention relates to a treatment process of a sulphur-containing hydrocarbon fraction, comprising the following steps: a) a hydrodesulphurization step of said hydrocarbon fraction to produce a sulphur-depleted effluent, consisting of passing the hydrocarbon fraction mixed with hydrogen over at least one hydrodesulphurization catalyst. b) a step of separation of the partially desulphurized hydrocarbon fraction from the hydrogen introduced in excess, as well as the H2S formed in step a). c) a step of collecting both mercaptans and thiophenic compounds, consisting of placing the partially desulphurized hydrocarbon fraction originating in step b) in contact with an adsorbent comprising at least one element chosen from the group constituted by the elements of groups VIII, IB, IIB and IVA, the adsorbent being used in reduced form in the absence of hydrogen at a temperature above 40° C., the metal content in the reduced form of the adsorbent being above 25% by weight.

Abstract: A belt-shaped base of a female member of a zipper tape attached to an inner surface of a bag body has a wide portion that extends wider toward an opening of the bag body than a belt-shaped base of the male member. An open tape is disposed on the wide portion and a seal layer is laminated on a surface of the open tape. A first projecting portion is also provided on the wide portion. A second projecting portion is provided on an opening-side end of the belt-shaped base. The projecting portions have a substantially trapezoidal cross section. When the zipper tape is bonded to the bag body and is sealed by the seal layer, a gap is provided between the open tape and the first and the second projecting portions.

Abstract: The present invention relates to fatty acid esters of polyols or sulfonated fatty acid esters or sulfonated fatty acid amides containing at least one group Y, where Y stands for CF3—(CH2)a—O—, SF5—, CF3—(CH2)a—S—, CF3CF2S—, [CF3—(CH2)a]2N— or [CF3—(CH2)a]NH—, where a stands for an integer selected from the range from 0 to 5, or formula (I), where Rf stands for CF3—(CH2)r—, CF3—(CH2)r—O—, CF3—(CH2)r—S—, CF3CF2—S—, SF5—(CH2)t— or [CF3—(CH2)r]2N—, [CF3—(CH2)r]NH— or (CF3)2N—(CH2)r—, B stands for a single bond, O, NH, NR, CH2, C(O)—O, C(O), S, CH2—O, O—C(O), N—C(O), C(O)—N, O—C(O)—N, N—C(O)—N, O—SO2 or SO2—O, R stands for alkyl having 1 to 4 C atoms, b stands for 0 or 1 and c stands for 0 or 1, q stands for 0 or 1, where at least one radical from b and q stands for 1, and r stands for 0, 1, 2, 3, 4 or 5, to processes for the preparation of these compounds, and to uses of these surface-active compounds.

Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, are novel effective HDAC inhibitors.

Abstract: Compounds of the formula (I): in which R, R1, R2 and R3 are as defined in the description, the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and processes for the preparation of these compounds.

Abstract: This invention provides a transparent oxide semiconductor, which comprises an oxide comprising indium oxide as a main component and cerium oxide as an additive and has such properties that light-derived malfunction does not occur, there is no variation in specific resistance of a thin film caused by heating and the like, and the mobility is high, and a process for producing the same. A semiconductor thin film characterized by comprising indium oxide and cerium oxide and being crystalline and having a specific resistance of 10+1 to 10+8 ?cm is used. This semiconductor thin film has no significant change in specific resistance and has high mobility. Accordingly, an element having improved switching properties can be provided by constructing a switching element using this semiconductor thin film.

Abstract: This invention concerns to N-(2-aylamino)aryl sulfonamides, which are inhibitors of MEK, methods of using such compounds in the treatment of hyperproliferative diseases, and to pharmaceutical compositions containing such compounds.

Abstract: A process and apparatus for the treatment of a gas that contains hydrogen sulfide and sulfurous anhydride, in which: a) the gas (3) contacts with an organic solvent (1) containing a catalyst in a gas-liquid reactor-contactor (2) so as to recover separately liquid sulfur and; a gas effluent containing sulfur vapor; subjecting the gas effluent to a first condensation zone (7) operating at 70-100° C. to deposit the sulfur in solid form on sufficiently cold walls of the equipment in zone (7), recovering resultant purified gas containing less than 30 ppm by volume of sulfur melting the deposited solid sulfur to regenerate the equipment, and recycling resultant liquefied sulfur to the reactor contactor.

Abstract: The invention relates to novel chemical compounds of Formula I compositions and methods of using the same. In particular, the invention provides pyridazine compounds and/or related heterocyclic derivatives, compositions comprising the same, and methods of using pyridazine compounds and/or related heterocyclic derivatives and compositions comprising the same, for modulation of cellular pathways (e.g., signal transduction pathways), for treatment or prevention of inflammatory diseases (e.g., Alzheimer's disease), for research, drug screening, and therapeutic applications.

Abstract: Novel triazabenzo[e]azulene derivatives of the formula, (I) in which R1, R2 and R3 have the meanings indicated in Claim 1, are inhibitors of TGF-beta receptor kinase and can be employed, inter alia, for the treatment of tumors.

Abstract: At least one chemical entity chosen from compounds of Formula 1 and pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, and mixtures thereof is described herein. Pharmaceutical compositions comprising at least one chemical entity of the invention, together with at least one pharmaceutically acceptable vehicle chosen from carriers adjuvants, and excipients, are described. Methods of treating patients suffering from certain diseases responsive to inhibition of Btk activity and/or B-cell activity are described. Methods for determining the presence of Btk in a sample are described.

Abstract: A process for the production of phenylalkanes comprising at least two catalytic alkylation reactors placed in parallel among which are present in reaction zones that each contain at least one acidic solid catalyst, whereby n is greater than or equal to 2, is described. One of the reactors carries out the alkylation of at least one aromatic compound by at least one olefin that has 9 to 16 atoms. An olefin fraction is introduced at the inlet of each of the reaction zones of the reactor that operates in alkylation mode. While one of the reactors carries out the alkylation, the other reactor carries out the reactivation of each catalyst, partially deactivated, that it contains. The functions of each reactor are switched regularly so as to limit the deactivation of catalysts in each of the reactors. The phenylalkanes that are obtained by the process according to the invention are particularly suitable for the production of detergents.

Abstract: Substituted indoles of the formula (I) and physiologically acceptable derivatives and salts thereof, in which R1, D, E, R12, p, X1, E, G, X2 and Z are as defined in Claim 1, exhibit particular actions on the central nervous system, especially 5HT reuptake-inhibiting and 5 HTx-agonistic and/or -antagonistic actions and in particular serotonin-agonistic and -antagonistic properties and can be employed as antipsychotics, neuroleptics, antidepressants, anxiolyties and/or antihypertonics. They can furthermore be employed as excitatory amino acid antagonists for combating neurodegenerative diseases, including cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction or psychoses.

Abstract: An anticorrosive pigment composition containing neither any heavy metal harmful to the environment nor zinc, which may be harmful to the environment. The composition is a product of the reaction of (a) aluminum dihydrogen tripolyphosphate, (b) a calcium compound selected among oxides, hydroxides, and carbonates, and (c) a magnesium compound selected among oxides, hydroxides, and carbonates. The composition exerts no adverse influence on the storage stability of water-based anticorrosive coating materials.

Abstract: The invention relates to a mass transfer or heat-exchange column, a tube bundle heat exchanger, with a first mass transfer or heat-exchange area, a first tube bundle (2), and a second mass transfer or heat-exchange area, in particular a second tube bundle (8), that is arranged spatially above the first mass transfer or heat-exchange area, which are surrounded by a cover (10?). In a tube bundle heat exchanger according to the invention, a lower end section (40) of the second, smaller tube bundle (8) projects into a cover part (13?) of the first, larger tube bundle (2), by which an intermediate space (41) is formed between the lower section (40) of the second tube bundle (8) and the cover part (13?). In the area of this intermediate space (41), an inlet (26) for injecting a medium into the column and optionally a manhole (36) are arranged on the cover part (13?).

Abstract: The present invention relates to compounds of the formula (I), where R1 to R3 each, independently of one another, denote H, hydroxyl or alkoxy having 1 to 8 C atoms, R4 denotes alkyl having 1 to 4 C atoms, H, hydroxyl or alkoxy having 1 to 8 C atoms, R5 denotes H or hydroxyl, and R6 denotes H or alkyl having 1 to 18 C atoms, or salts thereof, but where all R1 to R4 together cannot be equal to H, to compositions, and to the preparation and use thereof.

Abstract: The present invention relates to progesterone receptor antagonists of general formula I: in which R1 can be a hydrogen atom and R2 a hydroxyl group or R1 and R2 together can be an oxo group.

Abstract: The invention relates to a crystalline ion-conducting material made of LiMPO4 nanoparticles, wherein M is selected from Cr, Mn, Co, Fe and Ni, in addition to mixtures thereof and the nanoparticles have an essentially flat prismatic shape. The invention also relates to a method for producing said type of crystalline ion-conducting material which consists of the following steps: a precursor component is produced in a solution front a lithium compound of a component containing metal ions M and a phosphate compound, the precursor compound is subsequently precipitated from the solution and, optionally, a suspension of the precursor compound is formed, the precursor compound and/or the suspension is dispersed and/or ground, and the precursor compound and/or the suspension is converted under hydrothermal conditions and subsequently, the crystalline material is extracted.

Abstract: An optically detectable, floatable arsenic- and antimony-free, glazable lithium-aluminosilicate glass that can be prestressed and the glass ceramic converted therefrom are described. The glass or the glass ceramic has a composition (in % by weight based on oxide) of essentially SiO2 55-69, Al2O3 19-25, Li2O 3.2-5, Na2O 0-1.5, K2O 0-1.5, MgO 0-2.2, CaO 0-2.0, SrO 0-2.0, BaO 0-2.5, ZnO 0-<1.5, TiO2 1-3, ZrO2 1-2.5, SnO2 0.1-<1, ?TiO2+ZrO2+SnO2 2.5-5, P2O5 0-3, Nd2O3 0.01-0.6, CoO 0-0.005, F 0-1, B2O3 0-2.

Abstract: The invention relates to recombinant insect poison allergens and to a specific method for producing them. Said allergens can be varied according to whether they are produced using folds (conformations) that are identical or different to those that occur naturally. The proteins with folds that do not occur naturally have a reduced IgE reactivity or allergenity and can therefore be used as therapeutic agents in the immunotherapy of allergies.